|
Volumn 9, Issue 2, 2003, Pages 912-914
|
Correspondence re: C. G. Ferreira et al., Apoptosis: Target of cancer therapy. Clin. Cancer Res., 8: 2024-2034, 2002 (multiple letters)
a a a a b b b b |
Author keywords
[No Author keywords available]
|
Indexed keywords
LEUCINE ZIPPER PROTEIN;
RECOMBINANT PROTEIN;
TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
CANCER CELL CULTURE;
CYTOPATHOGENIC EFFECT;
DRUG CLEARANCE;
DRUG FORMULATION;
DRUG SELECTIVITY;
DRUG STABILITY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
HUMAN;
IN VITRO STUDY;
IN VIVO STUDY;
LETTER;
LIVER CELL CULTURE;
LIVER TOXICITY;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
PROTEIN STABILITY;
SPECIES DIFFERENCE;
APOPTOSIS;
APOPTOSIS REGULATORY PROTEINS;
HUMANS;
LIGANDS;
MEMBRANE GLYCOPROTEINS;
NEOPLASMS;
TNF-RELATED APOPTOSIS-INDUCING LIGAND;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0037314796
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (4)
|
References (0)
|